Amneal receives USFDA Approval for Prednisolone Acetate Ophthalmic Suspension
Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte.